| Pre-operative Zoledronate in Triple Negative Breast Cancer (NCT02347163) | Mario Negri Institute for Pharmacological Research | 2015-02-03 |
| Renal NCE-MRI in Healthy Volunteers (NCT02618460) | Mario Negri Institute for Pharmacological Research | 2015-01-01 |
| GREAT - Good Response With Appropriate Treatment (NCT02293785) | Mario Negri Institute for Pharmacological Research | 2014-11-01 |
| Eculizumab in Primary MPGN (NCT02093533) | Mario Negri Institute for Pharmacological Research | 2014-03-01 |
| L-Cysteine in Peritoneal Dialysis (NCT02050139) | Mario Negri Institute for Pharmacological Research | 2014-02-01 |
| Mesenchymal Stromal Cells in Kidney Transplant Recipients (NCT02012153) | Mario Negri Institute for Pharmacological Research | 2013-12-04 |
| An Efficacy Study Of Ortataxel In Recurrent Glioblastoma (NCT01989884) | Mario Negri Institute for Pharmacological Research | 2013-11-01 |
| Sevelamer in Proteinuric CKD (NCT01968759) | Mario Negri Institute for Pharmacological Research | 2013-10-01 |
| Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain (NCT01946555) | Mario Negri Institute for Pharmacological Research | 2013-09-01 |
| Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer (NCT01735071) | Mario Negri Institute for Pharmacological Research | 2013-07-01 |
| ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) (NCT02194231) | Mario Negri Institute for Pharmacological Research | 2013-07-01 |
| Pulsed Perfusion for Marginal Kidneys (NCT02055950) | Mario Negri Institute for Pharmacological Research | 2013-07-01 |
| Effects of Caloric Restriction in Obesity and Type 2 Diabetes (NCT01930136) | Mario Negri Institute for Pharmacological Research | 2013-05-01 |
| E-learning to Improve the Quality of Drug Prescribing in Hospitalized Elderly Patients (NCT02339792) | Mario Negri Institute for Pharmacological Research | 2012-11-01 |
| Multicentric Observational Study on Quality of Life in Glaucoma (NCT01742104) | Mario Negri Institute for Pharmacological Research | 2012-03-01 |
| CYCLosporinE A in Reperfused Acute Myocardial Infarction (NCT01650662) | Mario Negri Institute for Pharmacological Research | 2012-01-01 |
| Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes (NCT01393808) | Mario Negri Institute for Pharmacological Research | 2011-09-01 |
| INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer (NCT01379989) | Mario Negri Institute for Pharmacological Research | 2011-06-01 |
| Tolvaptan for In-hospital Hyponatremia (NCT01386372) | Mario Negri Institute for Pharmacological Research | 2011-06-01 |
| Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (NCT01377246) | Mario Negri Institute for Pharmacological Research | 2011-05-01 |
| Familiar Fatal Insomnia: Preventive Treatment With Doxycycline in Subject With Disease Risk (NCT04846335) | Mario Negri Institute for Pharmacological Research | 2011-04-28 |
| Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer (NCT01379976) | Mario Negri Institute for Pharmacological Research | 2011-04-01 |
| RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic Ladder. (NCT01809106) | Mario Negri Institute for Pharmacological Research | 2011-04-01 |
| CE-US in Renal Transplantation (NCT01815320) | Mario Negri Institute for Pharmacological Research | 2011-04-01 |
| ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach) (NCT01989858) | Mario Negri Institute for Pharmacological Research | 2010-11-01 |
| Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers (NCT01275612) | Mario Negri Institute for Pharmacological Research | 2010-11-01 |
| Efficacy of Nebulised Beclometasone in Viral Wheezing Prophylaxis (NCT01265342) | Mario Negri Institute for Pharmacological Research | 2010-10-01 |
| Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency (NCT01223755) | Mario Negri Institute for Pharmacological Research | 2010-09-01 |
| Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma (NCT02249702) | Mario Negri Institute for Pharmacological Research | 2010-04-01 |
| Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk (NCT01213212) | Mario Negri Institute for Pharmacological Research | 2009-09-01 |
| Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism (NCT01220050) | Mario Negri Institute for Pharmacological Research | 2009-09-01 |
| Remission Clinic in Proteinuric Chronic Nephropathies (NCT02721342) | Mario Negri Institute for Pharmacological Research | 2009-06-01 |
| Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis (NCT00985322) | Mario Negri Institute for Pharmacological Research | 2009-05-01 |
| Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS) (NCT00981838) | Mario Negri Institute for Pharmacological Research | 2009-04-01 |
| Telmisartan Versus Losartan in Kidney Transplantation (NCT01224860) | Mario Negri Institute for Pharmacological Research | 2009-01-01 |
| Nephrolithiasis Prevention by Lemon Juice (NCT01217372) | Mario Negri Institute for Pharmacological Research | 2009-01-01 |
| Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance (NCT00752479) | Mario Negri Institute for Pharmacological Research | 2008-05-01 |
| Acetyl-L-Carnitine in Type 2 Diabetes (NCT00984750) | Mario Negri Institute for Pharmacological Research | 2008-04-01 |
| Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia (NCT01052389) | Mario Negri Institute for Pharmacological Research | 2007-07-01 |
| Preventing Microalbuminuria in Type 2 Diabetes (NCT00503152) | Mario Negri Institute for Pharmacological Research | 2007-05-01 |
| Preventing ESRD in Overt Nephropathy of Type 2 Diabetes (NCT00494715) | Mario Negri Institute for Pharmacological Research | 2007-05-01 |
| MMF vs. AZA for Kidney Transplantation (NCT00494741) | Mario Negri Institute for Pharmacological Research | 2007-05-01 |
| Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety (NCT00491517) | Mario Negri Institute for Pharmacological Research | 2007-03-01 |
| Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study (NCT00309283) | Mario Negri Institute for Pharmacological Research | 2006-04-01 |
| Genetic Study of Nephrolithiasis in Gouty Diathesis (NCT00149305) | Mario Negri Institute for Pharmacological Research | 2005-05-01 |
| Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant (NCT00309309) | Mario Negri Institute for Pharmacological Research | 2005-04-01 |
| Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (NCT01640782) | Mario Negri Institute for Pharmacological Research | 2005-02-01 |
| Ezetimibe and Simvastatin in Dyslipidemia of Diabetes (NCT00157482) | Mario Negri Institute for Pharmacological Research | 2005-01-01 |
| Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk (NCT00317707) | Mario Negri Institute for Pharmacological Research | 2004-02-01 |
| Acetylcarnitine and Insulin Sensitivity (NCT00393770) | Mario Negri Institute for Pharmacological Research | 2004-02-01 |
| Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome (NCT00309257) | Mario Negri Institute for Pharmacological Research | 2004-01-01 |
| Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy (NCT00157508) | Mario Negri Institute for Pharmacological Research | 2003-03-01 |
| Statins in Proteinuric Nephropathies (NCT00199927) | Mario Negri Institute for Pharmacological Research | 2003-03-01 |
| Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation (NCT00309270) | Mario Negri Institute for Pharmacological Research | 2003-02-01 |
| Enzyme Replacement Therapy in Fabry Disease (NCT00149318) | Mario Negri Institute for Pharmacological Research | 2002-12-01 |
| L-Arginine in Pre-Eclampsia (NCT00157521) | Mario Negri Institute for Pharmacological Research | 2002-09-01 |
| Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) (NCT00157586) | Mario Negri Institute for Pharmacological Research | 2002-02-01 |
| Intensive Versus Minimal Surveillance of Patients With Resected Dukes B2-C Colorectal Carcinoma (NCT02409472) | Mario Negri Institute for Pharmacological Research | 1998-04-01 |